Sacral neuromodulation in diabetic patients: Success and complications in the treatment of voiding dysfunction
- 16 September 2009
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 29 (4) , 578-581
Abstract
Aims: We compared success rates, subsequent complications, and possible indications for success of sacral neuromodulation (SNM) for urinary voiding dysfunction in diabetic and non‐diabetic patients.Methods: Thirty‐two diabetic patients (mean age 61.8 years, range 27–83) with urge incontinence, urgency–frequency syndrome, and/or urinary retention refractory to non‐surgical treatment were retrospectively evaluated along with 211 non‐diabetic patients (mean age 54.1 years, range 20–86) with similar symptoms. All patients who experienced ≥50% reduction in urinary symptoms following a 7‐ to 21‐day test period went on to permanent SNM device implantation.Results: No significant difference was found with respect to successful conversion rates from the test period to permanent implantation between diabetic and non‐diabetic patients. Long‐term success rates at a mean followup of 29.3 months following permanent device implantation for diabetic patients were 69.2% of those with urge incontinence, 85.7% of those with urgency–frequency, and 66.7% of those with urinary retention. The non‐diabetic cohort had success rates of 67.0% for urge incontinence, 67.8% for urgency/frequency, and 58.2% for urinary retention (P = 0.823, 0.157, and 0.631, respectively). No patient experienced intraoperative complications. Nine of 24 (37.5%) devices were explanted postoperatively in diabetic patients compared with 36 of 141 (25.5%) in non‐diabetic patients (P = 0.224). The number of explants due to infection was higher in diabetic patients (16.7%) versus non‐diabetic patients (4.3%; P = 0.018).Conclusions: No difference in long‐term success rates was seen in diabetic patients when compared with similar, non‐diabetic patients. Diabetic patients did, however, have a higher incidence of device explantation due to infection. Neurourol. Urodynam.Keywords
This publication has 19 references indexed in Scilit:
- Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Outcomes of a Prospective, Worldwide Clinical StudyJournal of Urology, 2007
- Type 2 Diabetes Mellitus and Risk of Developing Urinary IncontinenceJournal of the American Geriatrics Society, 2005
- Bacterial contamination of test stimulation leads during percutaneous nerve stimulationUrology, 2005
- Recent advances in understanding the biology of diabetes‐associated bladder complications and novel therapyBJU International, 2005
- EFFECTS OF DIABETES ON FEMALE VOIDING BEHAVIORJournal of Urology, 2004
- Long‐term results of sacral neuromodulation for women with urinary retentionBJU International, 2004
- EFFICACY OF SACRAL NERVE STIMULATION FOR URINARY RETENTION: RESULTS 18 MONTHS AFTER IMPLANTATIONJournal of Urology, 2001
- QUANTIFYING RISK OF PENILE PROSTHESIS INFECTION WITH ELEVATED GLYCOSYLATED HEMOGLOBINJournal of Urology, 1998
- Risk Factors for Penile Prosthetic InfectionJournal of Urology, 1996
- Diabetic cystopathy—A risk factor in diabetic nephropathy?Journal of Diabetic Complications, 1988